B

Brown University Health

Remote behavioral health care platform analytics

Histotechnologist

Full-Time
$26.23 - $41.79
Mid
Associate's
Providence, RI, USA
In Person
Medical, Clinical & VeterinaryDiagnostics & Laboratory Professionals

About the job

Requirements
  • An associate degree in Applied Science or equivalent education and experience as defined by CLIA standards.
  • National certification, or eligibility for certification, in Histology by ASCP or equivalent.
  • Knowledge of histochemistry and techniques and procedures for preparing and processing tissue specimens for microscopic evaluation.
  • Analytical ability to troubleshoot instrumentation and quality-control problems, evaluate new procedures, and identify techniques to meet special-case requirements.
  • Ability to manipulate and mount microscopic tissues and sections onto slides and operate a rotary microtome.
  • Ability to perform gross and microscopic examinations of histological slides for quality-control purposes.
  • Interpersonal and communication skills to interact effectively with pathologists.
  • Demonstrated knowledge and skills necessary to provide patient care with consideration of aging processes, human development stages, and cultural patterns throughout the care process.
  • Experience in a clinical histology laboratory demonstrating familiarity with a wide range of histologic specimens and procedures, normally acquired through clinical training.
Responsibilities
  • Perform routine and non-routine specimen preparation in accordance with established policies and procedures.
  • Prepare specimens for microscopic evaluation and analysis by placing them in a tissue processor, embedding them in paraffin blocks, sectioning them with a rotary microtome, mounting them onto glass slides, and staining them with appropriate chemical solutions; coverslip and label slides and deliver them as instructed.
  • Identify and select techniques to process unusual or delicate specimens most effectively or to perform special staining or rush procedures, as requested by the manager or pathologist.
  • Assist the manager in monitoring and maintaining laboratory quality-control standards.
  • Perform gross and microscopic examinations of prepared histologic slides to check specimen orientation and angle, staining quality, and diagnostic value before release for diagnostic evaluation by a pathologist.
  • Identify unsatisfactory slides, determine the cause, and take corrective action as indicated.
  • Obtain and evaluate control materials using histologic technique and microscopic examination.
  • Input protocols to operate the tissue processor and make adjustments as necessary to meet special processing requirements; troubleshoot and correct malfunctions or arrange for servicing as appropriate.
  • Evaluate the effects of tissue-processing system shutdowns on tissue samples using knowledge of the time required to adequately fix varying sizes and types of tissue specimens, and determine and implement the most effective and timely alternative for specimen processing.
  • Participate in evaluation of new products, reagents, and procedures as requested by the manager.
  • Perform assigned duties that may include preparing frozen sections; preparing chemical dyes and solutions; decalcifying bone specimens; processing bone marrow specimens; and maintaining control logs.

About the company

B

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Get referred to Brown University Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • A $37 million Starr Foundation alliance launched September 2026 for aging research.
  • Brown Health targets 30,000 new primary-care patients and 27 hires over three years.
  • Primary-care waitlists fell from 14,000 to 4,800, showing access improvements.

What critics are saying

  • UnitedHealthcare Medicare Advantage cutoffs hit 1,900 members in July 2026, hurting referrals.
  • A Massachusetts data breach investigation remains unresolved, exposing patient trust and regulatory risk.
  • Fiscal 2025 margin was 0.9%; weak reimbursement can trigger another existential liquidity squeeze.

What makes Brown University Health unique

  • Brown University Health unites Lifespan hospitals with Brown University academic medicine since 2025.
  • Its 2025 Brown Physicians merger added 500-plus physicians and 1,500-plus providers.
  • Epic, Workday, and Brown-aligned research integration create a larger operating platform.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave
  • Productivity Bonus
  • Stock Options
  • Company Equity

Company News

Providence Business News
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

Providence Business News
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

Providence Business News
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

Providence Business News
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System